Oral lichen planus: A preliminary clinical study on treatment with tazarotene

Oral Diseases

Volumn 8, Issue 6, 2002, Pages 291-295

  Petruzzi, M ^a,c   De Benedittis, M ^a   Grassi, R ^a   Cassano, N ^b   Vena, G ^a   Serpico, R ^a  

^a UNIVERSITY OF BARI   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c NONE   (Italy)

Author keywords

Oral lichen planus; Retinoids; Tazarotene

Indexed keywords

PLACEBO; TAZAROTENE;

ADULT; AGED; ARTICLE; BURNING SENSATION; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HYPERKERATOSIS; INFLAMMATION; KERATINOCYTE; LICHEN PLANUS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SCORING SYSTEM; TASTE DISORDER; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; GELS; HUMANS; KERATINOCYTES; KERATOLYTIC AGENTS; LICHEN PLANUS, ORAL; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NICOTINIC ACIDS; PLACEBOS; REMISSION INDUCTION; RETINOIDS; SENSATION DISORDERS; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; TASTE DISORDERS; TREATMENT OUTCOME;

EID: 0036862279     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2002.02833.x     Document Type: Article

References (39)

1. Baudet-Pommel M, Janin-Mercier A, Souteyrand P, Peri G (1990). Ongoing clinical study of oral lichen planus (OLP) treated with retinoids: One used locally, (tretinoin) the other orally (etretinate). Actual Odontostomatol (Paris) 44: 337-348.
2. Baudet-Pommel M, Janin-Mercier A, Souteyrand P (1991). Sequential immunopathologic study of oral lichen planus treated with tretinoin and etretinate. Oral Surg Oral Med Oral Pathol 71: 197-202.
3. Boisnic C, Branchet MC, Pascal F, Ben Slama L, Rostin M, Szpirglas H (1994). Topical tretinoin in the treatment of lichen planus and leukoplakia of the mouth mucosa. A clinical evaluation. Ann Dermatol Venereol 121: 459-463.
4. Buajeeb W, Kraivaphan P, Pobrurksa C (1997). Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83: 21-25.
5. Burkhart CG, Burkhart CN (1998). Tazarotene gel for Darier's disease. J Am Acad Dermatol 38: 1001-1002.
6. Camisa C, Allen CM (1986). Treatment of oral lichen planus with systemic isotretinoin. Oral Surg 62: 393-396.
7. Carbone M, Conrotto D, Carrozzo M, Broccoletti R, Gandolfo S, Scully C (1999). Topical corticosteroids in association with miconazole and chlorexidine in the long-term management of atrophic-erosive lichen planus: A placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 5: 44-49.
8. Chandraratna RAS (1996). Tazarotene-first of a new generation of receptor-selective retinoids. Br J Dermatol 135: 18-25.
9. Chandraratna RAS (1997). Tazarotene: The first receptor-selective topical retinoid for the treatment of psoriasis. J Am Acad Dermatol 37: S12-S17.
10. Chandraratna RAS (1998). Rational design of receptor selective topical retinoids. J Am Acad Dermatol 39: S124-S128.
11. Chandraratna RAS, Klein ES (1998). Retinoid nuclear receptors. In: Lowe N, Marks R, eds. Retinoids. A Clinician's Guide, 2nd Edn. Martin Dunitz: London, pp. 21-32.
12. Duvic M (1997). A review of its pharmacological profile and potential for clinical use in psoriasis. Ex Opin Drugs 6: 1537-1551.
13. Duvic M (1998). Pharmacologic profile of tazarotene. Cutis 61: S22-S26.
14. Duvic M, Nagpal S, Asano AT, Chandraratna RAS (1997). Molecular mechanism of tazarotene action in psoriasis. J Am Acad Dermatol 37: 18-24.
15. Edwards KR, Bruke WA (1999). Treatment of localized discoid lupus erythematosus with tazarotene. J Am Acad Dermatol 41: 1049-1050.
16. Eisenberg E (2000). Oral lichen planus: A benign lesion. J Oral Maxillofac Surg 58: 1278-1285.
17. Ferguson MM, Simpson NB, Hammersly N (1984). The treatment of erosive lichen planus with a retinoid-etretinate. Oral Surg 58: 283-287.
18. Foster RH, Brogden RN, Benfield P (1998). Tazarotene. Drugs 55: 705-711.
19. Giustina TA, Stewart JC, Ellis CN et al (1986). Topical application of isotretinoin gel improves oral lichen planus. A double-blind study. Arch Dermatol 122: 534-536.
20. Gollnick H, Schramm M (1998). Topical drug treatment in acne. Dermatology 196: 119-125.
21. Gombos F, Serpico R (1999). Lichen planus orale. In: Gombos F, Serpico R, eds. Immunopatologia Orale. Piccin Editore: Padova, pp. 201-233.
22. Gunther SW (1973). Vitamin A acid in treatment of oral lichen planus. Arch Dermatol 107: 277.
23. Handler HL (1984). Isotretinoin for oral lichen planus. J Am Acad Dermatol 10: 674.
24. Hersle K, Mobacken H, Sloberg K, Thilander H (1982). Severe oral lichen planus: Treatment with an aromatic retinoid (etretinate). Br J Dermatol 106: 77-80.
25. Krueger GG, Drake LA, Elias PM et al (1998). The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. Arch Dermatol 134: 57-60.
26. Marks R (1997). Clinical safety of tazarotene in the treatment of plaque psoriasis. J Am Acad Dermatol 37: S25-S32.
27. Marks R (1998). Pharmacokinetics and safety review of tazarotene. J Am Acad Dermatol 39: S134-S138.
28. McCartan B, McCreary C (1999). What is the rationale for treating oral lichen planus? Oral Dis 5: 181-182.
29. Peris K, Fargnoli MC, Chimenti S (1999). Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. New Eng J Med 341: 1767-1768.
30. Piattelli A, Fioroni M, Santinelli A, Rubini C (1999). bcl-2 Expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: A pilot study. Oral Oncol 35: 314-20.
31. Regezi JA, Ellis CN, Stewart JC, Giustina TA (1986). Histological changes associated with the topical use of isotretinoin on oral lichen planus. Oral Surg Oral Med Oral Pathol 61: 479-484.
32. Setterfield JF, Black MM, Challacombe SJ (2000). The management of oral lichen planus. Clinic Exp Dermatol 25: 176-182.
33. Sloberg K, Hersele K, Mobacken H, Thilander H (1979). Topical tretinoin therapy and oral lichen planus. Arch Dermatol 115: 716-718.
34. Sloberg K, Hersele K, Mobacken H, Thilander H (1983). Severe oral lichen planus: Remission and maintenance with vitamin A analogues. Oral Pathol 12: 473-477.
35. Status ME, Bergfeld WF (1984). Treatment of oral lichen planus with low-dose isotretinoin. J Am Acad Dermatol 11: 527-528.
36. Tang-Liu DD, Matsumoto RM, Usansky JI (1999). Clinical pharmacokinetics and drug metabolism of tazarotene: A novel topical treatment for acne and psoriasis. Clin Pharmacokinet 37: 273-287.
37. Tege H, Hofmann B, Ruzicka T, Lehmann P (1998). Topical application of tazarotene in the treatment of nonerythrodermic lamellar ichtyosis (letter). Arch Dermatol 134: 640.
38. Woo TY (1985). Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis 35: 385-393.
39. Zegarelli D (1984). Treatment of oral lichen planus with topical vitamin A acid. J Oral Med 39: 186-191.